Masimo; Bmeye B.v.

AMSTERDAM and IRVINE, California, January 21 - BMEYE B.V., the innovators of combined noninvasive, beat-to-beat blood pressure and cardiac output monitoring, and Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, jointly announce today CE Mark certification and the European launch of the BMEYE ccNexfin-the first noninvasive cardiovascular monitor with Masimo Rainbow SET Pulse CO-Oximetry technology.